Alpha-glucosidase inhibitor, acarbose, improves glycamic control and reduces body weight in type 2 diabetes: Findings on indian patients from the pooled data analysis

Alpha-glucosidase inhibitor, acarbose, improves glycamic control and reduces body weight in type 2 diabetes: Findings on indian patients from the pooled data analysis

Alpha-glucosidase inhibitors are widely used especially in Asian countries as a treatment option for type 2 diabetes patients with high postprandial glycemia (PPG). The higher carbohydrate in the Indian diets lead to greater prandial glycemic excursion, increased glucosidase, and incretin activity i...

Full description

Bibliographic Details
Main Authors: Sanjay Kalra, R K Sahay, O Schnell, W. H. H. Sheu, W Grzeszczak, H Watada, S Soegondo, N Yamamoto, J Weng, R Rathod
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2013-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Acarbose
alpha glucosidase inhibitor
India
postprandial glycemia
type 2 diabetes
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2013;volume=17;issue=7;spage=307;epage=309;aulast=Kalra

Internet

http://www.ijem.in/article.asp?issn=2230-8210;year=2013;volume=17;issue=7;spage=307;epage=309;aulast=Kalra

Similar Items